3M: The Primary AFFF Manufacturer
3M Company of Saint Paul, Minnesota was the primary manufacturer of PFOS-based AFFF from the 1960s through its voluntary production halt in 2000. 3M developed AFFF in partnership with the United States Navy, which mandated the foam's use at all military airfields. For nearly four decades, 3M was the dominant supplier of AFFF to the Department of Defense, commercial airports, industrial facilities, and municipal fire departments. The company's Scotchgard and other consumer products also contained PFAS, but AFFF was the largest single source of PFAS environmental contamination.
3M's internal knowledge of PFAS toxicity is extensively documented through litigation discovery. In the 1970s, 3M's own studies found PFAS in workers' blood at 1,000 times normal levels. Company toxicologists concluded that PFOA and PFOS "should be regarded as toxic." 3M hired Professor John Giesy to conduct research designed to keep the PFAS science "company-friendly." Despite knowing of the persistence, bioaccumulation, and toxicity of PFAS, 3M continued manufacturing and selling AFFF without warning users for another 24 years.
3M has paid enormous sums to resolve PFAS claims: $10.3 billion for water utility settlements (2023), $850 million to the State of Minnesota (2018), and additional amounts in smaller settlements. In 2023, 3M announced it would exit PFAS manufacturing entirely by the end of 2025 — a decision driven by the scale of litigation and regulatory liability. Despite these payments, the company's personal injury exposure in MDL 2873 remains substantial, with over 15,216 individual claims pending.
DuPont: The PFOA Story
E.I. du Pont de Nemours and Company — known simply as DuPont — manufactured PFOA (perfluorooctanoic acid) at its Washington Works facility in Parkersburg, West Virginia from the 1950s through 2015. DuPont used PFOA in the production of Teflon and other fluoropolymer products, and the chemical was released into the Ohio River and surrounding air, contaminating the drinking water of communities across the Mid-Ohio Valley for decades.
DuPont's concealment of PFOA toxicity is one of the most extensively documented cases of corporate malfeasance in environmental law. In 1980, two of eight pregnancies among PFOA-exposed workers resulted in birth defects — DuPont did not disclose this to regulators or workers. Throughout the 1990s, DuPont's animal studies showed PFOA caused tumors in laboratory rats — the company continued discharging PFOA into the environment. Attorney Robert Bilott's landmark litigation against DuPont, beginning with the Tennant case in 2001, forced the creation of the C8 Science Panel and exposed decades of corporate concealment.
DuPont has since restructured into three separate companies: DuPont de Nemours (the successor company), Chemours (spun off in 2015 to assume fluorochemical liabilities), and Corteva Agriscience (spun off in 2019). Together, these three entities settled water utility claims for $1.185 billion and previously settled approximately 3,550 C8 personal injury claims for $670.7 million. The corporate restructuring has been criticized as an attempt to isolate liabilities, but all three successor entities remain defendants in MDL 2873.
The combined liability of 3M, DuPont and its successors, and other AFFF manufacturers and distributors for personal injury claims represents one of the largest remaining exposures in environmental mass tort litigation. The evidence of corporate knowledge and concealment — spanning decades and documented through internal company records — provides the foundation for both compensatory and punitive damages claims.
Scientific Evidence
Meta-Analysis of PFAS Exposure and Cancer Risk: Kidney and Testicular Cancer
Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Corigliano P. (2023). La Medicina del Lavoro
Key Findings
- Relative risk of 1.74 for kidney cancer among individuals with high PFAS exposure compared to low-exposure controls
- Relative risk of 2.22 for testicular cancer among individuals with high PFAS exposure — the strongest relative risk of any PFAS-cancer association
- Dose-response relationship demonstrated: higher PFAS blood levels correlated with progressively higher cancer risk
- Results consistent across multiple study designs and populations, strengthening the causal inference
"The Devil They Knew": Industry Knowledge of PFAS Dangers Since 1970
Brennan NM, Evans AT, Fritz MK, Peak SA, von Holst HE. (2023). Annals of Global Health
Key Findings
- PFAS manufacturers knew about the persistence and toxicity of their products as early as 1970 — more than 50 years before widespread public awareness
- 3M conducted internal studies showing PFAS bioaccumulation in worker blood at 1,000 times normal levels and animal studies showing tumor formation, then classified results as confidential
- Manufacturers used trade secret protections and proprietary research agreements to prevent damaging findings from reaching regulators or the public
- The pattern of corporate concealment parallels the tobacco and asbestos industries and supports punitive damages claims based on willful and malicious conduct
C8 Science Panel: Probable Link Evaluations for PFOA-Associated Diseases
Fletcher T, Savitz D, Steenland K. (2012). Environmental Health Perspectives
Key Findings
- Determined "probable link" between PFOA exposure and six diseases: kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, high cholesterol, and pregnancy-induced hypertension
- Study population of 69,000 residents made it one of the largest PFAS health studies ever conducted, providing exceptional statistical power
- Findings have been cited in virtually every subsequent PFAS lawsuit and regulatory action worldwide
- The "probable link" standard — requiring more than just association but less than definitive proof — was a negotiated scientific threshold that has become the benchmark for PFAS causation evidence
Frequently Asked Questions
Related Pages
AFFF Firefighter Cancer Claims
Firefighters have the highest documented PFAS blood levels of any occupational group and form the core of the AFFF personal injury litigation. Municipal, airport, and military firefighters who trained with AFFF absorbed PFAS through skin contact and inhalation of foam mist, often for years or decades without protective equipment. NIOSH studies show elevated cancer rates among firefighters, and many states have enacted presumptive cancer laws that create favorable conditions for firefighter AFFF claims.
AFFF Kidney Cancer Lawsuit
Kidney cancer (renal cell carcinoma) has the strongest scientific link to PFAS exposure of any cancer. IARC classified PFOA as a Group 1 carcinogen based largely on kidney cancer evidence. Meta-analyses show a relative risk of 1.74 for kidney cancer at high PFAS exposure levels. The C8 Science Panel determined a "probable link" between PFOA and kidney cancer based on the 69,000-person Mid-Ohio Valley study. Firefighters and military personnel with kidney cancer and AFFF exposure history have among the strongest claims in MDL 2873.
AFFF Military Base Contamination
The Department of Defense has identified PFAS contamination at more than 455 military installations where AFFF was used for fire training and emergency response. Air Force bases, Naval air stations, and Marine Corps installations are the most heavily affected. Service members, their families, and surrounding communities were exposed for decades through contaminated drinking water. Military personnel can file AFFF lawsuits against the foam manufacturers while also receiving VA benefits.
AFFF Settlement Amounts
AFFF/PFAS litigation has produced over $12.5 billion in water utility settlements and $670.7 million in C8 personal injury settlements. The personal injury track in MDL 2873 — with 15,216+ claims — is advancing toward bellwether trials that will establish settlement benchmarks. Based on the C8 precedent (averaging ~$189,000 per claim) and the severity of PFAS-linked conditions, projected personal injury settlements range from $25,000 for moderate cases to $2 million or more for severe cases.
AFFF Testicular Cancer Lawsuit
Testicular cancer has the highest relative risk of any PFAS-linked cancer, with meta-analyses showing RR=2.22 for high PFAS exposure — meaning more than double the cancer risk. The C8 Science Panel determined a "probable link" between PFOA and testicular cancer. Testicular cancer is most common in younger men (ages 15-35), making it particularly relevant for military personnel and younger firefighters exposed to AFFF early in their careers.
AFFF Thyroid Disease Lawsuit
Thyroid disease is one of six conditions with a C8 Science Panel "probable link" to PFOA exposure. PFAS are potent endocrine disruptors that interfere with thyroid hormone synthesis and metabolism, causing hypothyroidism, hyperthyroidism, and thyroid cancer. Thyroid disease is often the earliest clinical manifestation of PFAS exposure and may affect a broader population than PFAS-linked cancers, making it significant for the AFFF litigation.
AFFF Water Contamination Lawsuit
PFAS from AFFF have contaminated the drinking water of an estimated 100 million Americans. Water utility settlements exceeding $12.5 billion have been approved in MDL 2873, but personal injury claims from individuals who drank contaminated water remain active. The EPA's 2024 drinking water standard of 4 ppt for PFOA/PFOS confirmed that previously "safe" levels were actually harmful. Community residents who developed PFAS-linked diseases from contaminated water have viable personal injury claims.
AFFF Firefighting Foam Lawsuit
AFFF firefighting foam containing per- and polyfluoroalkyl substances (PFAS) has been used since the 1960s at military bases, airports, and fire training facilities across the United States. These "forever chemicals" do not break down in the environment and have contaminated groundwater, soil, and drinking water supplies serving millions of Americans. The C8 Science Panel established "probable links" between PFAS exposure and six diseases including kidney cancer, testicular cancer, and thyroid disease. MDL 2873, consolidated before Judge Richard Gergel in the District of South Carolina, encompasses over 15,216 personal injury claims against manufacturers including 3M, DuPont, Chemours, Tyco Fire Products, and BASF. Water utility settlements exceeding $12.5 billion have been approved, and the personal injury track is advancing toward bellwether trials with Daubert motions and expert depositions underway.
View full case overview